Innovation Pharmaceuticals Financials

Innovation Pharmaceuticals Stock Summary

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Innovation Pharmaceuticals Key Financial Ratios

Innovation Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from Innovation Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of Innovation Pharmaceuticals over time and compare it to other companies across industries.

Innovation Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innovation Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Innovation Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovation Pharmaceuticals competition to find correlations between indicators driving Innovation Pharmaceuticals's intrinsic value. More Info.Innovation Pharmaceuticals is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovation Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovation Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Along with financial statement analysis, the daily predictive indicators of Innovation Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innovation Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innovation Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Innovation Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innovation Pharmaceuticals's daily price indicators and compare them against related drivers.

When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.